Evidence map›Paper›PMID 17982023›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2007

Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor.

Jill M Kramer, Walter Hanel, Fang Shen, Nilgun Isik, James P Malone, Amarnath Maitra, Wade Sigurdson, David Swart, Joel Tocker, Tian Jin and 1 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. IL-17 Signaling: The Yin and the Yang.Trends in immunology · 2017
    Review
  4. Article
  5. Role of IL-17 in psoriasis and psoriatic arthritis.Clinical reviews in allergy & immunology · 2013
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy.Laboratory investigation; a journal of technical methods and pathology · 2011
    Article
  12. Article
  13. [Pathogenesis of parodontitis in rheumatic diseases].Zeitschrift fur Rheumatologie · 2010
    Review
  14. IL-17RC: a partner in IL-17 signaling and beyond.Seminars in immunopathology · 2010
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jill M KramerDepartment of Oral Biology, University at Buffalo, State University of New York, Buffalo, NY 14214, USA.
Walter Hanel
Fang Shen
Nilgun Isik
James P Malone
Amarnath Maitra
Wade Sigurdson
David Swart
Joel Tocker
Tian Jin
Sarah L Gaffen

Funding

TRAINING PROGRAM IN PERIODONTAL DISEASEST32DE007034 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SCANNAPIECO, FRANK ANDREW · 1985 to 2008
$3.5M
G-protein Coupled Receptor Mediated Directional SensingZ01AI000916 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI JIN, TIAN · 2002 to 2008
$1.2M
Anti-Apoptotic Signaling by the IL-2/15 ReceptorR01AI049329 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GAFFEN, SARAH L. · 2002 to 2006
$1.2M
Using FRET to Probe the Spatial Distributions of CD4, CXCR4 and CCR5 on MembraneZ01AI000928 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI JIN, TIAN · 2003 to 2008
$906k
Signaling by a Tyrosine-Deficient IL-2/15 Receptor BetaR21AI049329 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GAFFEN, SARAH L. · 2001 to 2001
$267k
Individual Predoctoral Scientist FellowshipF30DE014831 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI KRAMER, JILL MARIE · 2002 to 2005
$139k
TITANIUM ALLOYS FOR PARTIAL DENTURESR43DE007034 · NIDCR · GREENMARK, INC. · PI MARKER, BERNARD C · 1985 to 1985
–
Intramural NIH HHSNIAID NIH HHS AI49329NIAID NIH HHS R01 AI049329NIAID NIH HHS R21 AI049329NIAMS NIH HHS AR05048NIDCR NIH HHS DE07034NIDCR NIH HHS DE14831NIDCR NIH HHS F30 DE014831NIDCR NIH HHS T32 DE007034
6 · The paper itself

Abstract

IL-17 is the hallmark cytokine of the newly described "Th17" lymphocyte population. The composition, subunit dynamics, and ligand contacts of the IL-17 receptor are poorly defined. We previously demonstrated that the IL-17RA subunit oligomerizes in the membrane without a ligand. In this study, computational modeling identified two fibronectin-III-like (FN) domains in IL-17RA connected by a nonstructured linker, which we predicted to mediate homotypic interactions. In yeast two-hybrid, the membrane-proximal FN domain (FN2), but not the membrane-distal domain (FN1), formed homomeric interactions. The ability of FN2 to drive ligand-independent multimerization was verified by coimmunoprecipitation and fluorescence resonance energy transfer microscopy. Thus, FN2 constitutes a "pre-ligand assembly domain" (PLAD). Further studies indicated that the FN2 linker domain contains the IL-17 binding site, which was never mapped. However, the FN1 domain is also required for high affinity interactions with IL-17. Therefore, although the PLAD is located entirely within FN2, effective ligand binding also involves contributions from the linker and FN1.

Indexed as

Models, MolecularBinding SitesCell LineFluorescence Resonance Energy TransferHumansInterleukin-17LigandsLymphocytesPeptide MappingProtein BindingProtein Structure, QuaternaryProtein Structure, TertiaryReceptors, Interleukin-17Two-Hybrid System TechniquesIL17RA protein, humanInterleukin-17LigandsReceptors, Interleukin-17

Identifiers

PMID17982023
PMCPMC2973996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.